Global Animal Vaccines Market by Animal Type (Companion, Ruminants, Poultry, Aqua) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global animal vaccines market was valued at USD 9.2 Billion in 2020. It is projected to grow at a compound annual rate (CAGR of 7.4%) between 2021 and 2028. Market dynamics have changed due to the constant introduction of new vaccines and the spread of diseases in livestock. Market dynamics have changed from living attenuated vaccines to DNA vaccinations. Recombinant vaccines are quickly being adopted.

The market for animal vaccines will continue to be innovative, and there will be frequent acquisitions and strategic alliances. Competitive advantage will depend on product development and competent distribution channels. Market growth will be driven by the increasing demand for animal-derived foods products and regulatory mandates.

All industries were affected by the COVID-19 pandemic, even animal vaccines. OIE currently confirms that this virus cannot be spread from animals. However, there have been cases of human-to-animal transmission in some countries. IDEXX Laboratories has tested a lot of dogs and cats for the virus. Test results have been negative. There was speculation that the virus could spread to birds during the initial months of this pandemic. This negatively affected the livestock industry. After the outbreak, many U.S. poultry and pig processing plants were closed. Due to concerns and fears about the novel coronavirus, India's poultry industry has already lost approximately USD 1 billion.

In India, 9 states were affected by the bird flu epidemic in December 2020. The overall impact on the livestock industry has been severed by the drop in the prices of poultry products. According to the Poultry Federation of India (PFI), chicken consumption has dropped to 50% and prices have fallen by 30% as of December 2020. India is the only country that has not adopted vaccine policies in Asia. The Haryana and Punjab state governments are close in legalizing vaccinations. This could have a positive impact on the market.

Human lives can be negatively affected by zoonotic disease, which will likely increase the demand for animal vaccines. The CDC released a list of the top 8 infectious diseases that are easily transmitted from animals to people in May 2019. This was done in partnership with USDA and the U.S. Department of the Interior. These diseases include salmonellosis and West Nile virus. The CDC has taken steps to protect people against zoonotic disease.

Product Insights

Attenuated live vaccinations dominated the market for animal vaccins in 2020 and had a revenue share exceeding 36.0%. Live attenuation, the oldest method of vaccination in the veterinary world, is still being used. The development of new applications is currently underway for this method. One of these options is the development of intramuscular protein subunit vaccines. These products help reduce mortality and increase the lifespan of disease-affected swine.

Over the forecast period, the recombinant vaccine market is expected to grow at a lucrative rate. These vaccinations reduce the risk of animal pathogenicity after vaccination. Because recombinant vaccines can be infused with multiple gene inserts, they are expected to aid in vaccination against multiple strains of virus. These vaccine formulations can be made without the use of adjuvants and increase the vaccine's viability and stability. There are a few recombinant vaccines that can be used for veterinarian medicine. These include vaccines against canine distemper and pseudorabies as well as Lyme disease, Lyme disease, Lyme disease, Lyme disease and avian flu.

Information on Animal Types

In 2020, the highest revenue share was held by the ruminants segment of the animal vaccines market. It accounted for over 25% of the total revenue. This dominance can be attributed to factors like rising livestock populations, supportive government initiatives, and the outbreak of diseases in cattle and sheep. Globally, there were approximately 1,200 PPR-related outbreaks in 2019, compared with 3,500 in 2015. This was due to a vaccination campaign by FAO and partners in over 50 countries, which is further propelling market.

The fastest expected growth is in the poultry segment during the forecast period. This segment is driven by a high consumption of poultry products daily. The demand for poultry products will increase by approximately 20% by 2028, according to estimates. High-quality poultry products can be produced using a wide variety of pharmaceuticals, vaccines, and feeds. This expands the potential for growth. Due to growing consumer awareness and high demand for poultry products, the poultry market is a top investment area.

Regional Insights

North America was the dominant market, accounting for 26.6% of the total revenue in 2020. This region will continue to dominate the market for the entire forecast period. The high incidence of livestock diseases and zoonotic disease that can cause large-scale animal death is responsible for the large market share. The market growth is expected to be boosted by the presence of established pharmaceutical companies that are constantly striving to increase their commercialization and geographic reach. The market share is also being boosted by the increasing incidence of canine diseases and the growing pet population in the United States.

The fastest growing market in Asia Pacific is anticipated to be during the forecast period. Market growth will be boosted by the expected increase in livestock population and government initiatives, especially in developing countries. The National Dairy Development Board 2019 estimates that India has 192.5 million cattle. This huge country's cattle population calls for high vaccine demand. High R&D spending by major players and rising attempts to commercialize veterinary vaccines at low prices are the main drivers of this market.

Market Share Insights & Key Companies

This market is highly competitive, and is dominated by a variety of small and large-scale animal vaccine manufacturers. Competition is influenced by rapid adoption of preventive injections for veterinary purposes and government-aided bulk purchases of vaccines.

Major players often choose to diversify their product portfolio and use various strategies in order to maintain share. Ceva, for example, partnered with INRAE in February 2021 for R&D on infectious diseases prevention and animal health . Zoetis introduced the Poulvac Procerta HVT–IBD vaccine to protect poultry from Infectious Bursal Disease (IBD) in January 2021. This was added to the company’s portfolio of recombinant vaccines. Among the most prominent players in animal vaccines are:

• Merck & Co., Inc.

• Zoetis

• Boehringer Ingelheim International GmbH

• Virbac

• Biogenesis Bago,

• Indian Immunologicals Ltd.

• Elanco

• Ceva

• Phibro Animal Health Corporation

• Neogen Corporation

• Intas Pharmaceuticals Ltd

• Ourofino Saude Animal

Up Market Research published a new report titled “Animal Vaccines Market research report which is segmented by Animal Type (Companion, Ruminants, Poultry, Aqua), By Players/Companies Zoetis, Neogen Corporation, Virbac, Biog©nesis Bag³, Ourofino Saºde Animal, Boehringer Ingelheim International GmbH, Phibro Animal Health Corporation, Intas Pharmaceuticals Ltd, Ceva, Indian Immunologicals Ltd, Elanco, Merck & Co Inc”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Animal Vaccines Market Report Segments:

The market is segmented by Animal Type (Companion, Ruminants, Poultry, Aqua).

Animal Vaccines Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Animal Vaccines Market

Overview of the regional outlook of the Animal Vaccines Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Animal Vaccines Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Animal Vaccines Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Companion

                2. Ruminants

                3. Poultry

                4. Aqua

7. Market scenario by region, sub-region, and country.
8. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
9. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
10. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Animal Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Animal Vaccines Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.